Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$828M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$788M |
| 3 |
Qualcomm
QCOM
|
+$771M |
| 4 |
Apple
AAPL
|
+$719M |
| 5 |
Baxter International
BAX
|
+$571M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.57B |
| 2 |
Wells Fargo
WFC
|
+$967M |
| 3 |
KKR & Co
KKR
|
+$455M |
| 4 |
Booking.com
BKNG
|
+$401M |
| 5 |
GGP
GGP Inc.
GGP
|
+$384M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.32% |
| 2 | Technology | 13.38% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 9.31% |
| 5 | Consumer Discretionary | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
326
Globant
GLOB
$1.57B
| $231M | 0.06% |
3,916,084
+289,250
| +8% | +$17M |
2014 Q3
16 quarters
|
|
327
A.O. Smith
AOS
$7.66B
| $231M | 0.06% |
4,323,398
+845,117
| +24% | +$49.6M |
2013 Q2
21 quarters
|
|
328
Stanley Black & Decker
SWK
$13.4B
| $230M | 0.06% |
1,573,755
+95,116
| +6% | +$13.5M |
2013 Q2
21 quarters
|
|
329
Vanguard Financials ETF
VFH
$12.8B
| $230M | 0.06% |
3,314,912
-72,597
| -2% | -$5.13M |
2013 Q2
21 quarters
|
|
330
Fomento Económico Mexicano
FMX
$40.6B
| $228M | 0.06% |
2,306,864
-116,216
| -5% | -$11.2M |
2013 Q2
21 quarters
|
|
331
Berkshire Hathaway Class A
BRK.A
$1.11T
| $227M | 0.06% |
709
-17
| -2% | -$5.26M |
2013 Q2
21 quarters
|
|
332
iShares MSCI ACWI ETF
ACWI
$33.3B
| $224M | 0.06% |
3,016,467
-527,176
| -15% | -$38.6M |
2013 Q2
21 quarters
|
|
333
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.45B
| $221M | 0.06% |
4,335,445
+395,612
| +10% | +$20.2M |
2016 Q2
9 quarters
|
|
334
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.73B
| $219M | 0.05% |
6,917,034
-354,544
| -5% | -$11.4M |
2013 Q2
21 quarters
|
|
335
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.7B
| $219M | 0.05% |
2,616,417
-510,146
| -16% | -$42.7M |
2013 Q2
21 quarters
|
|
336
Ross Stores
ROST
$71B
| $218M | 0.05% |
2,201,584
+898,614
| +69% | +$82.6M |
2013 Q2
21 quarters
|
|
337
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.34B
| $216M | 0.05% |
3,992,317
+254,656
| +7% | +$13.8M |
2013 Q2
21 quarters
|
|
338
Align Technology
ALGN
$10.1B
| $215M | 0.05% |
549,192
-48,478
| -8% | -$17.9M |
2013 Q2
21 quarters
|
|
339
Corning
GLW
$135B
| $215M | 0.05% |
6,084,855
+573,273
| +10% | +$18.6M |
2013 Q2
21 quarters
|
|
340
Block Inc
XYZ
$46.4B
| $213M | 0.05% |
2,155,014
-663,568
| -24% | -$51.2M |
2015 Q4
11 quarters
|
|
341
iShares Preferred and Income Securities ETF
PFF
$12.2B
| $213M | 0.05% |
5,730,769
-212,004
| -4% | -$7.95M |
2013 Q2
21 quarters
|
|
342
Canadian Pacific Kansas City
CP
$74.2B
| $212M | 0.05% |
5,007,510
+1,376,675
| +38% | +$55.1M |
2013 Q2
21 quarters
|
|
343
iShares Floating Rate Bond ETF
FLOT
$11.1B
| $212M | 0.05% |
4,146,168
+362,000
| +10% | +$18.5M |
2013 Q2
21 quarters
|
|
344
Western Digital
WDC
$149B
| $211M | 0.05% |
4,770,439
+2,044,551
| +75% | +$104M |
2013 Q2
21 quarters
|
|
345
Vanguard Health Care ETF
VHT
$19.3B
| $211M | 0.05% |
1,167,773
+171,012
| +17% | +$29.4M |
2013 Q2
21 quarters
|
|
346
Capital One
COF
$122B
| $211M | 0.05% |
2,218,793
-225,606
| -9% | -$21.9M |
2013 Q2
21 quarters
|
|
347
Oneok
OKE
$56.6B
| $208M | 0.05% |
3,060,954
+693,501
| +29% | +$47.5M |
2013 Q2
21 quarters
|
|
348
Charles Schwab
SCHW
$167B
| $207M | 0.05% |
4,213,413
-261,055
| -6% | -$13.3M |
2013 Q2
21 quarters
|
|
|
CERN
349
DELISTED
Cerner Corp
CERN
| $206M | 0.05% |
3,201,690
+649,256
| +25% | +$41.3M |
2013 Q2
21 quarters
|
|
350
iShares US Medical Devices ETF
IHI
$3.55B
| $205M | 0.05% |
5,401,278
+1,353,636
| +33% | +$48.1M |
2013 Q2
21 quarters
|
|
Similar funds
Morgan Stanley's Q3 2018 Portfolio in Review
As of Q3 2018, Morgan Stanley held 7,051 positions worth $400B, up 7.9% from $370B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2018 filing shows 207 new, 2,867 increased, 3,205 reduced and 166 closed positions. Its largest new stake was Elanco Animal Health: 9,012,591 shares worth $314M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.57B.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, down from 30% a quarter earlier, followed by Technology and Healthcare.
- Morgan Stanley's largest Q3 2018 buy was Elanco Animal Health: 9,012,591 shares worth $314M.
- Morgan Stanley added most to Intuitive Surgical in Q3 2018, an estimated $828M increase.
- Morgan Stanley's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.57B.
- Morgan Stanley fully exited GGP Inc. in Q3 2018, selling an estimated $384M.
- Morgan Stanley's ten largest holdings make up 15% of its $400B portfolio in Q3 2018.
- Morgan Stanley opened 207 new positions and closed 166 in Q3 2018.
- Morgan Stanley's portfolio value rose 7.9% quarter-over-quarter to $400B.
Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.